<DOC>
	<DOCNO>NCT02793648</DOCNO>
	<brief_summary>The trial aim treat depression . The incidence major depression elderly account 3.6 4.8 % increase 8 37.4 % depressive disorder general study . Besides depression elderly present cognitive impairment , impaired physical social functioning , predispose suicide . These patient often multiple condition take numerous psychopharmacological treatment hinders treatment . The clinical trial analyze improvement neuropsychiatric symptom different instrument The Beck Depression Inventory ( BDI ) , State-Trait Anxiety Inventory ( STAI ) , Life Events ( AV ) , World Health Organization Disability Assessment Schedule 2.0 ( WHODAS 2.0 ) , Wechsler Memory Scale ( WMS-III ) , Mini mental state examination ( MMSE ) , Clinical Global Impression ( CGI ) metabolic change blood test measurement ; 12 week antioxidant ( Ascorbic acid Tocopherol ) treatment placebo , 24 week active treatment antioxidant combination ( Ascorbic acid Tocopherol ) .</brief_summary>
	<brief_title>Effectiveness Ascorbic Acid Tocopherol Depression Elderly .</brief_title>
	<detailed_description>Objective : To evaluate effect combination antioxidant Ascorbic acid tocopherol , therapy depressive disorder elderly . - Design : Pilot clinical trial , Phase II , 6-month randomize , double-blind placebo-controlled one-way crossover clinical trial , two treatment period 12 week duration . - Setting : Regional University Hospital , Malaga . - Subjects : people older tan 55 year diagnose depression . - Intervention : 50 participant randomly assign , receive antioxidant vitamin C ( ascorbic acid ) vitamin E ( d-alpha-tocopherol ) day placebo 12 week double-blind . In Study Period 2 , participant receive ( open ) active treatment . Outcome measure : improvement depressive symptom . Plasma antioxidant status , also memory assess Wechsler Memory Scale ( WMS-III ) , cognitive improvement analyze use Mini mental state examination ( MMSE ) 0 , 3 , 6 month trial .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<criteria>Diagnosis mild moderate depression Mini International Neuropsychiatric Interview ( MINI ) . Having 55 year old Have sign inform consent document start participation trial Any advance severe unstable disease . Previous diagnose / presence severe mental disorder . Risk suicidal behavior . Any treatment regimen , include treatment psychotropic drug / anticonvulsant therapy stable period â‰¥ 4 week prior randomization . Current treatment two psychoactive medication , include medication seizure control . Intake 100 mg vitamin E C day last 4 month . Hypoprothrombinemia secondary vitamin K deficiency Glucose 6phosphate dehydrogenase deficiency ( G6PD ) . Treatment oral anticoagulant . Initiate change pharmacological nonpharmacological intervention course trial . Allergy formula component ( excipient use )</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Elderly</keyword>
</DOC>